ThePigSite Latest News
Boehringer Ingelheim Receives APHIS Approval on new Circovirus Vaccine
US - Boehringer Ingelheim Vetmedica, Inc., (BIVI) has announced that it has received approval from the U.S. Animal and Plant Health Inspection Service for a new vaccine called Ingelvac® CircoFLEX™ to protect swine against diseases caused by porcine circovirus type 2 (PCV2).by the Iowa Department of Natural Resources.
According to Klaas Okkinga, marketing manager for BIVI, Ingelvac CircoFLEX is a single-dose, 1 ml vaccine that provides the highest level of efficacy and safety to pigs.
“It’s highly effective in immunizing pigs as young as 3 weeks of age prior to exposure to PCV2, and provides long-lasting protection without the systemic irritation and tissue reactions some vaccines can cause.”
In addition, Ingelvac CircoFLEX has a short 21-day withdrawal period and positive pork quality assurance benefits that are important to producers, Okkinga adds.
“It has been thoroughly field tested and we are confident this vaccine will help producers more effectively prevent porcine circovirus associated disease.”
Ingelvac CircoFLEX will be widely available to US producers in 2007.
| ThePigSite News Desk | Read more Boehringer Ingelheim News here |
Latest Pig Industry News
Market Preview: Watch for Feed Buying Opportunities- Weekly Review: Phenomenal Pork Export Demand
- Rabobank: Pork Profitability to Return by End of 2009
Exciting Opportunities Created by PCV2 Genotype- Flexible Protection Offered by PCV2 Vaccine
TOPIGS SA Delivers Sows to Frey’s Food Brand- Pork Checkoff's Future Leaders Receive Sponsorship
ACMC: Tips to Avoid Autumn Infertility
Cost Effective Deadstock Removal Option Offered- Disease Protocols for Animals and People
